Fidelity Advisor Series VII (CIK 315700) is an SEC-registered fund company with 12 reporting fund series and $26.6B in net assets as of 2026-04-30.
| Holding | Value |
|---|---|
| ELI LILLY and CO | $200.0M |
| DANAHER CORP | $196.0M |
| JOHNSON and JOHNSON | $163.7M |
| THERMO FISHER SCIENTIFIC INC | $104.4M |
| UNITEDHEALTH GROUP INC | $87.1M |
| BOSTON SCIENTIFIC CORP | $80.7M |
| ASCENDIS PHARMA A/S | $78.0M |
| ALNYLAM PHARMACEUTICALS INC | $70.6M |
| GILEAD SCIENCES INC | $65.4M |
| ABBVIE INC | $64.2M |
| UCB SA | $59.2M |
| ARGENX SE | $50.8M |
| BRIGHTSPRING HEALTH SERVICES INC | $48.0M |
| CENCORA INC | $44.2M |
| MERCK and CO INC | $43.7M |